Company / Interest Expense
ENvue Medical, Inc. Interest Expense History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$135.0K
FY2024
5-year range
$135.0K / $347.0K
FY2020-FY2024
Trend
-61.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $347,000 to $135,000 over the past 2 years.
Based on SEC 10-K filings.
$135,000 in FY2024 with a 5-year CAGR of +55.2%.
Improved from $347,000 to $135,000 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -2.8%
- 5-Year CAGR
- +55.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +55.2%, indicating consistent growth.
- In FY2024, interest expense decreased 61.1% year-over-year.
- Peak interest expense was recorded in FY2023.
- Lowest interest expense in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $135.0K | -61.1% |
| FY2023 | $347.0K | +0.0% |
| FY2022 | $347.0K | +136.1% |
| FY2021 | $147.0K | +880.0% |
| FY2020 | $15.0K | +0.0% |
| FY2019 | $15.0K | -59.5% |
| FY2018 | $37.0K | +0.0% |
| FY2017 | $37.0K | -43.1% |
| FY2016 | $65.0K | -82.5% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026